Our Research Publications

Updated November 2023

Title Authors Year Journal Link to Article Intended Audience Purpose
Factor XIa-specific aptamers Sheffield WP, Donkor DA 2017 European Patent Office View Industry New or improved product or process
ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men Walsh G 2022 Blood.ca website View Regulators MSM research
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF 2022 Transfusion View Regulators MSM research
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic Prokopchuk-Gauk O, Petraszko T, Nahirniak S, Doncaster C, Levy I 2021 Transfusion View Regulators Benchmarking and standard setting
Regulatory decisions pertaining to aprotinin may be putting patients at risk Hebert PC, Fergusson DA, Hutton B, Mazer CD, Fremes S, Blajchman M, MacAdams C, Wells G, Robblee J, Bussieres J, Teoh K 2014 CMAJ View Regulators Other
Validation of administrative database codes for acute kidney injury in kidney transplant recipients Molnar AO, van Walraven C, McArthur E, Fergusson D, Garg AX, Knoll G 2016 Can J Kidney Health Dis View Regulators New or improved product or process
Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006–2008: a Canadian Immunization Research Network study Hughes SL, Kwong JC, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Mahmud SM, Crowcroft NS 2022 Can J Public Health View Regulators Clinical research
Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains Spindler-Raffel E, Benjamin RJ, McDonald CP, Ramirez-Arcos S, Aplin K, Bekeredjian-Ding I, de Korte D, Gabriel C, Gathof B, Hanschmann KM, Hourfar K, Ingram C, Jacobs MR, Keil SD, Kou Y, Lambrecht B, Marcelis J, Mukhtar Z, Nagumo H, Niekerk T, Rojo J, Marschner S, Satake M, Seltsam A, Seifried E, Sharafat S, Stormer M, Sussner S, Wagner SJ, Yomtovian R 2017 Vox Sang View Regulators Benchmarking and standard setting
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility Holloway K, Simms N, Hayeems RZ, Miller FA 2022 Hastings Cent Rep View Regulators Ethical, legal and social implications research
Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J 2013 Vox Sang View Regulators New or improved product or process
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J 2013 Transfusion View Regulators New or improved product or process
Early warning and rapid public health response to prevent COVID-19 outbreaks in long-term care facilities (LTCF) by monitoring SARS-CoV-2 RNA in LTCF site-specific sewage samples and assessment of antibodies response in this population: prospective study protocol Lee BE, Sikora C, Faulder D, Risling E, Little LA, Qiu Y, Gao T, Bulat R, Craik S, Hrudey SE, Ohinmaa A, Estabrooks CA, Gingras A-C, Charlton C, Kim J, Wood H, Robinson A, Kanji JN, Zelyas N, O’Brien SF, Drews S, Pang X-L 2021 BMJ Open View Regulators New or improved product or process
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option Chen ZY 2022 Blood.ca website View Regulators New or improved product or process
Concentré de recherche: Le risque de transmission du VIH est demeuré inchangé avec l’élargissement des critères d’admissibilité aux hommes gais, bisexuels et autres hommes ayant des rapports sexuels avec d’autres hommes Walsh G 2022 Blood.ca website View Regulators MSM research
Quality assessment of established and emerging blood components for transfusion Acker J, Marks DC, Sheffield W 2016 J Blood Transfus View Blood operators Benchmarking and standard setting
Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors Saeed S, Goldman M, Uzicanin S, O'Brien SF 2021 Transfusion View Blood operators New or improved product or process
Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 Haw J, Thorpe R, Holloway K 2021 SocArXiv View Blood operators Ethical, legal and social implications research
Summary of adverse transfusion reactions 2017-2022 Yan M 2022 Blood.ca website View Blood operators Benchmarking and standard setting
Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations Hodgson SD, Greco-Stewart V, Jimenez CS, Sifri CD, Brassinga AKC, Ramirez-Arcos S 2014 Transfusion View Blood operators Basic research
Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw Bhakta V, Jenkins C, Ramirez-Arcos S, Sheffield WP 2014 Transfusion View Blood operators New or improved product or process
Transfusion science: integration of proteomics with blood banking Schubert P, Devine DV 2011 Rev Mex Med Tran View Blood operators Other
Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services Goldman M, Uzicanin S, Yi QL, Acker JP, Ramirez-Arcos S 2012 Transfusion View Blood operators New or improved product or process
Vox Sanguinis International Forum on Donor Incentives: Summary Zeller MP, Ellingham D, Devine D, Lozano M, Lewis P, Zhiburt E, van der Linde L, Goldman M, Nakamura A, Inoue S, Takikawa M, Nakajima K, Turek P, Rehacek V, Sakashita AM, Kutner JM, Karim FA, Hindawi S, Jayasekara SBA, Merz EM, Gross S, Woimant G, Djoudi R, Byabazaire KD, Irving DO, Abdrakhmanova S, Khalykova A, Yilmaz S, Oruc NE, Huaynalaya IP, Ramirez LAS, Chuhriiev A 2020 Vox Sang View Blood operators Benchmarking and standard setting
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Girardin R, Dupuis A, McDonough K, Lin J, Evans D, Pambrun C, Drebot M, Wood H 2022 Transfus Med Rev View Blood operators New or improved product or process
Changing the 30-min Rule in Canada: The Effect of Room Temperature on Bacterial Growth in Red Blood Cells Ramirez-Arcos S, Kou Y, Ducas É, Thibault L 2016 Transfus Med Hemother View Blood operators Benchmarking and standard setting
Comparison of donor and general population demographics over time: a BEST collaborative group study Goldman M, Steele WR, Di Angelantonio E, van den Hurk K, Vassallo RR, Germain M, O'Brien SF 2017 Transfusion View Blood operators Clinical research
Establishment of the first International Repository for Transfusion-Relevant Bacteria Reference Strains: ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID), Subgroup on Bacteria Stormer M, Arroyo A, Brachert J, Carrero H, Devine D, Epstein JS, Gabriel C, Gelber C, Goodrich R, Hanschmann KM, Heath DG, Jacobs MR, Keil S, de Korte D, Lambrecht B, Lee CK, Marcelis J, Marschner S, McDonald C, McGuane S, McKee M, Muller TH, Muthivhi T, Pettersson A, Radziwon P, Ramirez-Arcos S, Reesink HW, Rojo J, Rood I, Schmidt M, Schneider CK, Seifried E, Sicker U, Wendel S, Wood EM, Yomtovian RA, Montag T 2012 Vox Sang View Blood operators Benchmarking and standard setting
Impact of sample volume and handling time during analysis on the in vitro quality measurements of platelet concentrates held in syringes Schubert P, Culibrk B, Coupland D, Levin E, Devine DV 2011 Int J Lab Hematol View Blood operators New or improved product or process
Vox Sanguinis International Forum on donor notification and counselling strategies for markers of transfusion?transmissible infections: Summary Sharma R, Lozano M, Fearon M, Bigham M, Djoudi R, Gallian P, Woimant G, Lee C, Leung J, Tsoi W 2017 Vox Sang View Blood operators New or improved product or process
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men Castillo G, Vesnaver E, Gibson E, Butler-Foster T, Goldman M, Hill NE, Rosser A, Lapierre D, Rubini KA, MacDonagh R, Miguel G, Palumbo A, MacPherson P, Randall T, Osbourne-Sorrell W, O'Brien SF, Bridel W, Otis J, Greaves M, Al-Bakri TB, Reid M, Labrecque M, Germain M, Orvis S, Clapperton AT, Devine D, Presseau J 2022 Transfusion View Blood operators MSM research
White paper on pandemic preparedness in the blood supply Strengers P, O'Brien SF, Politis C, Mayr W, Seifried E, Spencer BR 2023 Vox Sang View Blood operators Benchmarking and standard setting
A fresh look at measuring quality in blood components Devine DV, Chen D 2014 ISBT Sci Ser View Blood operators Other
AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections AABB Clinical Transfusion Medicine Committee, Heddle NM, Boeckh M, Grossman B, Jacobson J, Kleinman S, Tobian AAR, Webert K, Wong ECC, Roback JD 2016 Transfusion View Blood operators Clinical research
Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measures van der Meer PF, Cancelas JA, Cardigan R, Devine DV, Gulliksson H, Sparrow RL, Vassallo RR, de Wildt-Eggen J, Baumann-Baretti B, Hess JR, for the BC 2011 Transfusion View Blood operators New or improved product or process
Platelet concentrates from fresh or overnight-stored blood, an international study Dijkstra-Tiekstra MJ, van der Meer PF, Cardigan R, Devine D, Prowse C, Sandgren P, de Wildt-Eggen J, for the Biomedical Excellence for Safer Transfusion C 2011 Transfusion View Blood operators New or improved product or process
The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors O'Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA 2013 Transfus Med View Blood operators Clinical research
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP 2021 Cytotherapy View Blood operators New or improved product or process
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative 2022 Vox Sang View Blood operators Benchmarking and standard setting
Sommaire des réactions transfusionnelles indésirables Yan M 2022 Blood.ca website View Blood operators Benchmarking and standard setting
Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study Cardigan R, Van der Meer PF, Pergande C, Cookson P, Baumann-Baretti B, Cancelas JA, Devine D, Gulliksson H, Vassallo R, de Wildt-Eggen J 2011 Transfusion View Blood operators New or improved product or process
Exploring resource allocation and alternate clinic accessibility landscapes for improved blood donor turnout Paez A, Esita J, Newbold KB, Heddle NM, Blake JT 2013 Appl Geogr View Blood operators New or improved product or process
Impact of a 5-year deferral from blood donation for men who have sex with men O'Brien SF, Osmond L, Fan W, Yi Q-L, Goldman M 2015 Transfusion View Blood operators Benchmarking and standard setting
Stepping Stones or Second Class Donors?: a qualitative analysis of gay, bisexual, and queer men's perspectives on plasma donation policy in Canada Grace D, Gaspar M, Klassen B, Lessard D, Anand P, Brennan DJ, Lachowsky N, Adam BD, Cox J, Lambert G, Jollimore J, Hart TA 2021 BMC Public Health View Blood operators MSM research
An expanded role for blood donor emerging pathogens surveillance O’Brien SF, Goldman M, Drews S 2023 CMAJ View Blood operators New or improved product or process
Impact of technical and assay variation on reporting of hemolysis in stored red blood cell products Almizraq RJ, Yi QL, Acker JP 2017 Clinica Chimica Acta View Blood operators New or improved product or process
Lipoprotein enrichment in orange insoluble particulate matter reproducibly appearing in cryoprecipitate Sheffield WP, Bhakta V, Trigatti B, Jenkins C 2011 Vox Sang View Blood operators Basic research
Vox Sanguinis International Forum on platelet cryopreservation Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Poglod R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M 2017 Vox Sang View Blood operators New or improved product or process
Concentré de recherche: Des questions de sélection fondées sur le comportement sexuel?: comprendre et atténuer le?malaise des donneurs Woo H 2022 Blood.ca website View Blood operators MSM research
A generic modelling framework to evaluate network blood management policies: The Canadian Blood Services experience Blake JT, Hardy M 2014 Oper Res Health Care View Blood operators New or improved product or process
Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer no to risk questions O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Huang M, Ndao M, Fearon MA 2014 Transfusion View Blood operators New or improved product or process